6.00
Treace Medical Concepts Inc stock is traded at $6.00, with a volume of 288.73K.
It is up +2.04% in the last 24 hours and down -16.90% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$5.88
Open:
$5.98
24h Volume:
288.73K
Relative Volume:
0.90
Market Cap:
$379.04M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-5.8697
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-4.76%
1M Performance:
-16.90%
6M Performance:
-10.91%
1Y Performance:
+14.07%
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TMCI
Treace Medical Concepts Inc
|
6.00 | 371.46M | 198.53M | -63.68M | -41.50M | -1.0222 |
![]()
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
Dec-31-24 | Initiated | Lake Street | Buy |
Dec-17-24 | Resumed | JP Morgan | Neutral |
May-16-24 | Downgrade | UBS | Buy → Neutral |
May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
May-08-24 | Downgrade | Stifel | Buy → Hold |
May-08-24 | Downgrade | Truist | Buy → Hold |
Sep-29-23 | Initiated | UBS | Buy |
May-01-23 | Initiated | Truist | Buy |
Apr-11-23 | Initiated | Stephens | Equal-Weight |
May-12-22 | Initiated | BTIG Research | Buy |
Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
May-18-21 | Initiated | JP Morgan | Overweight |
May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
May-18-21 | Initiated | SVB Leerink | Outperform |
May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Regression analysis insights on Treace Medical Concepts Inc. performanceMarket Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Will Treace Medical Concepts Inc. stock go up soonRecession Risk & Community Consensus Picks - newser.com
Is Treace Medical Concepts Inc. stock trading at a premium valuation2025 Major Catalysts & Safe Capital Growth Plans - newser.com
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
Treace Medical Concepts Inc. stock daily chart insightsJuly 2025 Closing Moves & Community Verified Trade Signals - newser.com
Chart overlay techniques for tracking Treace Medical Concepts Inc.Quarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - ACCESS Newswire
Will Treace Medical Concepts Inc. continue its uptrend2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Farther Finance Advisors LLC Purchases New Holdings in Treace Medical Concepts, Inc. $TMCI - Defense World
Weiss Ratings Reiterates Sell (E+) Rating for Treace Medical Concepts (NASDAQ:TMCI) - MarketBeat
Using data models to predict Treace Medical Concepts Inc. stock movement2025 Trading Volume Trends & Comprehensive Market Scan Insights - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Published on: 2025-10-09 03:28:29 - newser.com
Visual analytics tools that track Treace Medical Concepts Inc. performanceEntry Point & Daily Oversold Bounce Ideas - newser.com
Multi asset correlation models including Treace Medical Concepts Inc.Trade Exit Summary & Weekly Breakout Watchlists - newser.com
Treace Medical Concepts, Inc. $TMCI Shares Purchased by Gagnon Securities LLC - MarketBeat
Gagnon Advisors LLC Raises Position in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Insiders' US$524.1k Investments In Red Following Treace Medical Concepts' US$45m Dip In Market Value - simplywall.st
Why Treace Medical Concepts Inc. is moving todayQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Long term hold vs stop loss in Treace Medical Concepts Inc.2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Is Treace Medical Concepts Inc. stock reversal real or fakeCPI Data & Long-Term Growth Plans - newser.com
Trend analysis for Treace Medical Concepts Inc. this weekQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com
Published on: 2025-10-06 02:57:11 - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-10-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation | NDAQ:TMCI | Press Release - Stockhouse
Treace Medical Concepts Inc. stock momentum explainedIndex Update & Low Risk High Reward Ideas - newser.com
What institutional flow reveals about Treace Medical Concepts Inc.Quarterly Performance Summary & Technical Entry and Exit Tips - newser.com
Reversal indicators forming on Treace Medical Concepts Inc. stockWeekly Profit Report & Long-Term Growth Portfolio Plans - newser.com
Published on: 2025-10-03 04:27:44 - newser.com
Applying Wyckoff theory to Treace Medical Concepts Inc. stockTrade Risk Report & Weekly Sector Rotation Insights - newser.com
Can Treace Medical Concepts Inc. stock withstand economic slowdownJuly 2025 Earnings & Capital Efficiency Focused Ideas - newser.com
Treace Medical Concepts Inc Stock Analysis and Forecast - earlytimes.in
How geopolitical tensions affect Treace Medical Concepts Inc. stock2025 Historical Comparison & Stepwise Trade Signal Implementation - newser.com
Visualizing Treace Medical Concepts Inc. stock with heatmaps2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
Important Notice to Long-Term Shareholders of DoubleVerify - GlobeNewswire
About Us - FinancialContent
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Treace Medical Concepts Inc Stock (TMCI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Option Exercise |
1.05 |
50,000 |
52,500 |
414,081 |
Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Sale |
7.97 |
50,000 |
398,460 |
364,081 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):